Pathophysiology Quiz: Raas And Volume Regulation
20 questions · exam conditions
0:00
Raas And Volume RegulationQuestion 1 of 20

A patient with severe cirrhosis and ascites is treated with high-dose furosemide. Despite initial diuresis, their ascites reaccumulates, and they develop hypokalemia. Spironolactone is added to their regimen.

What is the primary rationale for adding spironolactone to furosemide in this patient?

To directly block sodium reabsorption in the proximal tubule, which is unaffected by furosemide.
To counteract the secondary hyperaldosteronism that drives diuretic resistance and potassium wasting.
To increase the synthesis of natriuretic peptides, which are deficient in patients with cirrhosis.
To inhibit the action of ADH at the collecting duct, promoting aquaresis and correcting hyponatremia.
← Back to quizzes

Pathophysiology Quiz

Pathophysiology Quiz: Raas And Volume Regulation

Practice Raas And Volume Regulation in Pathophysiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Raas And Volume Regulation, giving you a quick way to practice the rules, question types, and explanations that matter most for Pathophysiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient with severe cirrhosis and ascites is treated with high-dose furosemide. Despite initial diuresis, their ascites reaccumulates, and they develop hypokalemia. Spironolactone is added to their regimen.

What is the primary rationale for adding spironolactone to furosemide in this patient?

  1. To directly block sodium reabsorption in the proximal tubule, which is unaffected by furosemide.
  2. To counteract the secondary hyperaldosteronism that drives diuretic resistance and potassium wasting. (correct answer)
  3. To increase the synthesis of natriuretic peptides, which are deficient in patients with cirrhosis.
  4. To inhibit the action of ADH at the collecting duct, promoting aquaresis and correcting hyponatremia.
Explanation: The correct answer is B. In cirrhosis, splanchnic vasodilation reduces effective circulating volume, leading to profound activation of the RAAS (secondary hyperaldosteronism). High levels of aldosterone drive intense sodium reabsorption in the distal nephron. While furosemide blocks sodium reabsorption in the loop of Henle, much of this sodium is reabsorbed downstream under the influence of aldosterone. This limits furosemide's efficacy (diuretic resistance) and exacerbates potassium secretion. Spironolactone, an aldosterone antagonist, directly blocks this downstream effect, enhancing natriuresis and conserving potassium.

Question 2

A patient with heart failure and an ejection fraction of 25% is maintained on an ACE inhibitor and a beta-blocker. His labs show a serum creatinine of 1.8 mg/dL. He is prescribed a high dose of a nonsteroidal anti-inflammatory drug (NSAID) for severe osteoarthritis pain and subsequently develops acute kidney injury.

What is the most likely mechanism for the NSAID-induced acute kidney injury in this patient?

  1. NSAID-induced acute interstitial nephritis, an allergic reaction within the kidney.
  2. Direct nephrotoxic tubular injury from accumulation of the NSAID metabolite.
  3. Combined afferent arteriole constriction and efferent arteriole dilation, severely reducing glomerular pressure. (correct answer)
  4. Inhibition of ADH, leading to profound dehydration and prerenal azotemia.
Explanation: The correct answer is C. In a low-flow state like heart failure, GFR is maintained by two key mechanisms: 1) Prostaglandins dilate the afferent arteriole to maintain blood flow into the glomerulus, and 2) Angiotensin II constricts the efferent arteriole to maintain pressure within the glomerulus. This patient is on an ACE inhibitor, which blocks angiotensin II, thus dilating the efferent arteriole. The addition of an NSAID blocks prostaglandin synthesis, leading to constriction of the afferent arteriole. The combination of afferent constriction and efferent dilation causes a precipitous drop in intraglomerular hydrostatic pressure, leading to a sharp decline in GFR and acute kidney injury.

Question 3

During a normal third-trimester pregnancy, plasma volume is expanded by 40-50%, cardiac output is increased, yet systemic vascular resistance and blood pressure are typically lower than pre-pregnancy levels. Which of the following best describes the state of the renin-angiotensin-aldosterone system (RAAS) during this time?

  1. The RAAS is suppressed due to the significant expansion of plasma volume.
  2. The RAAS is highly activated, but the vasculature is refractory to the pressor effects of angiotensin II. (correct answer)
  3. RAAS activity is unchanged from the non-pregnant state, as hormonal effects are balanced by volume changes.
  4. Aldosterone levels are elevated, but renin and angiotensin II levels are suppressed by placental hormones.
Explanation: The correct answer is B. Pregnancy presents a physiological paradox for the RAAS. Estrogen increases hepatic synthesis of angiotensinogen, and the placenta produces renin. These factors, combined with systemic vasodilation (caused by progesterone and other vasodilators), lead to a massive activation of the RAAS, with very high levels of renin, angiotensin II, and aldosterone. This is necessary to promote the volume retention required for pregnancy. However, the maternal vasculature develops a refractoriness or resistance to the vasoconstrictive effects of angiotensin II, which is why blood pressure does not rise and often falls.

Question 4

A 40-year-old female is diagnosed with primary hyperaldosteronism (Conn's syndrome) due to an adrenal adenoma. She has hypertension and hypokalemia but lacks significant peripheral edema.

The absence of severe edema in this patient is best explained by which physiological phenomenon?

  1. Suppression of renin and angiotensin II, which counteracts the sodium-retaining effects of aldosterone.
  2. The "aldosterone escape" mechanism, involving increased pressure natriuresis and ANP release. (correct answer)
  3. Downregulation of mineralocorticoid receptors in the collecting duct after prolonged stimulation.
  4. A paradoxical decrease in ADH secretion despite the hypervolemic state.
Explanation: The correct answer is B. In primary hyperaldosteronism, the initial aldosterone-driven sodium and water retention causes volume expansion and hypertension. This expansion increases renal perfusion pressure and stretches the cardiac atria, leading to pressure natriuresis and the release of Atrial Natriuretic Peptide (ANP). ANP promotes sodium and water excretion by increasing GFR and directly inhibiting sodium reabsorption in the collecting duct. This counter-regulatory response allows the kidney to "escape" the full sodium-retaining effect of aldosterone, establishing a new steady state with mild hypervolemia and hypertension but without progressive edema formation.

Question 5

A 62-year-old male with resistant hypertension undergoes an evaluation that reveals 90% stenosis of his left renal artery. The right kidney and its artery are anatomically normal. Renal vein catheterization is performed to measure renin levels from both kidneys.

Which of the following patterns of renin secretion is expected in this patient?

  1. Markedly elevated renin from the left renal vein and suppressed renin from the right renal vein. (correct answer)
  2. Markedly elevated renin from both the left and right renal veins.
  3. Suppressed renin from the left renal vein and markedly elevated renin from the right renal vein.
  4. Suppressed renin from both the left and right renal veins due to high systemic blood pressure.
Explanation: The correct answer is A. The stenosis in the left renal artery causes profound hypoperfusion of the left kidney. The juxtaglomerular apparatus of the left kidney interprets this as systemic hypotension and dramatically increases renin secretion. This high level of renin enters the systemic circulation, activating the RAAS and causing severe hypertension. The healthy right kidney is exposed to this high systemic blood pressure, which, along with high levels of angiotensin II, provides strong negative feedback to its juxtaglomerular cells, suppressing its renin release.

Question 6

A patient is given an experimental drug that selectively and potently blocks the AT2 receptor, leaving the AT1 receptor unaffected. What is the most likely physiological consequence of administering this drug?

  1. A significant decrease in blood pressure and natriuresis.
  2. Inhibition of aldosterone release with preservation of vasoconstrictor effects.
  3. A clinical picture identical to that of an ACE inhibitor, including cough.
  4. An unopposed, exaggerated effect of AT1 receptor stimulation, such as increased vasoconstriction. (correct answer)
Explanation: When you encounter questions about selective receptor blockade, think about the balance between opposing receptor subtypes and what happens when you tip that balance. The renin-angiotensin system has two main receptor types with opposing effects. AT1 receptors mediate the "bad" effects of angiotensin II: vasoconstriction, aldosterone release, and sodium retention. AT2 receptors generally oppose these actions, promoting vasodilation, natriuresis, and anti-proliferative effects. These receptors normally work in balance to modulate angiotensin II's overall impact. By selectively blocking AT2 receptors while leaving AT1 receptors intact, you remove the counterbalancing effects. Now angiotensin II can only bind to AT1 receptors, creating an unopposed, exaggerated response. This means enhanced vasoconstriction, increased aldosterone release, and greater sodium retention - essentially amplifying all the harmful cardiovascular effects. Answer D correctly identifies this unopposed AT1 stimulation. Answer A is backwards - blocking the protective AT2 receptors would increase blood pressure and reduce natriuresis. Answer B misunderstands the receptor roles; AT2 blockade wouldn't inhibit aldosterone (that's an AT1 effect) but would actually allow more aldosterone release. Answer C incorrectly assumes AT2 blockade mimics ACE inhibition, when it actually does the opposite - ACE inhibitors reduce angiotensin II formation, while AT2 blockade shifts existing angiotensin II toward harmful AT1 effects. Remember: when studying receptor systems, always consider whether receptors work synergistically or antagonistically. Blocking one member of an antagonistic pair amplifies the other's effects.

Question 7

A patient switches from an ACE inhibitor (lisinopril) to an angiotensin II receptor blocker (ARB) (losartan) due to a persistent cough. How would this change in medication be expected to affect the circulating levels of renin, angiotensin I, and angiotensin II?

  1. Angiotensin II levels will increase, while renin and angiotensin I levels will decrease.
  2. Angiotensin II, angiotensin I, and renin levels will all increase. (correct answer)
  3. Angiotensin II levels will decrease, similar to the effect of an ACE inhibitor.
  4. Angiotensin II and angiotensin I will decrease, while renin levels will increase.
Explanation: The correct answer is B. ARBs block the AT1 receptor, preventing angiotensin II from exerting its effects, including negative feedback on renin release. The loss of this negative feedback loop leads to a compensatory increase in plasma renin activity. Increased renin leads to increased production of angiotensin I, and subsequently, increased conversion to angiotensin II (since ACE is not inhibited). Thus, levels of all three components (renin, Ang I, and Ang II) increase, although the effects of Ang II are blocked at the receptor level.

Question 8

The integration of the baroreceptor reflex and the RAAS is essential for blood pressure homeostasis. Following a sudden, severe hemorrhage, which of the following represents the most rapid compensatory vasoconstrictor response?

  1. Increased aldosterone release causing sodium and water retention.
  2. Increased angiotensin II formation leading to systemic vasoconstriction.
  3. Increased norepinephrine release from sympathetic nerve terminals. (correct answer)
  4. Increased ADH release from the posterior pituitary.
Explanation: The correct answer is C. The baroreceptor reflex is the body's fastest mechanism for responding to changes in blood pressure. A drop in pressure, as seen in hemorrhage, is sensed by baroreceptors in the carotid sinus and aortic arch. This leads to a near-instantaneous increase in sympathetic outflow from the brainstem. The release of norepinephrine at vascular smooth muscle nerve endings causes rapid, widespread vasoconstriction to increase total peripheral resistance and support blood pressure within seconds.

Question 9

A 68-year-old male with a history of decompensated systolic heart failure is admitted with worsening dyspnea, jugular venous distention, and 3+ pitting edema in his lower extremities. His blood pressure is 95/65 mmHg. Laboratory results show a serum sodium level of 128 mEq/L (Normal: 135-145 mEq/L).

Which of the following is the primary pathophysiological mechanism responsible for the hyponatremia observed in this patient?

  1. Excessive renal sodium loss due to high-dose loop diuretic therapy.
  2. Pressure natriuresis stimulated by elevated atrial and ventricular filling pressures.
  3. Non-osmotic release of antidiuretic hormone (ADH) leading to impaired free water excretion. (correct answer)
  4. Over-activation of natriuretic peptides (ANP and BNP) in response to cardiac stretch.
Explanation: The correct answer is C. In decompensated heart failure, low cardiac output leads to decreased effective circulating volume. This is sensed by baroreceptors, triggering potent non-osmotic stimuli for ADH release (via carotid sinus and aortic arch reflexes) and activating the RAAS. Angiotensin II also stimulates ADH release. The elevated ADH increases water reabsorption in the collecting ducts, leading to a dilutional hyponatremia because water is retained in excess of sodium.

Question 10

A 30-year-old patient presents with hypertension, hypokalemia, and metabolic alkalosis. Plasma renin activity and aldosterone levels are both found to be very low.

Which of the following conditions best explains this constellation of findings?

  1. Liddle syndrome, due to a gain-of-function mutation in the epithelial sodium channel (ENaC). (correct answer)
  2. Primary hyperaldosteronism (Conn's syndrome) from an aldosterone-producing adenoma.
  3. Renal artery stenosis leading to secondary hyperaldosteronism.
  4. Glucocorticoid-remediable aldosteronism (GRA) due to a chimeric gene fusion.
Explanation: The correct answer is A. Liddle syndrome is a rare genetic disorder causing a gain-of-function mutation in the ENaC in the collecting ducts. This leads to excessive sodium reabsorption and potassium secretion, mimicking hyperaldosteronism. However, because the process is independent of aldosterone, the resulting volume expansion and hypertension suppress both renin and aldosterone production. The clinical picture is therefore one of apparent mineralocorticoid excess with low aldosterone levels.

Question 11

A 59-year-old female is being treated for hypertension and diabetic nephropathy with an angiotensin-converting enzyme (ACE) inhibitor. She presents to the emergency department with generalized weakness, palpitations, and ascending muscle paralysis. An ECG reveals peaked T waves and a widened QRS complex.

The patient's clinical presentation is most likely caused by which of the following effects of her medication?

  1. Inhibition of bradykinin degradation leading to angioedema and respiratory compromise.
  2. Reduced aldosterone secretion leading to impaired renal potassium excretion. (correct answer)
  3. Decreased efferent arteriolar tone causing an acute drop in glomerular filtration rate.
  4. Suppression of thirst and ADH release resulting in severe hyponatremia.
Explanation: The correct answer is B. The patient's symptoms (weakness, paralysis) and ECG findings (peaked T waves, wide QRS) are classic for severe hyperkalemia. ACE inhibitors block the conversion of angiotensin I to angiotensin II. Reduced angiotensin II levels lead to decreased aldosterone secretion from the adrenal cortex. Since aldosterone's primary function is to promote potassium secretion in the distal nephron, its inhibition results in potassium retention and can lead to hyperkalemia, especially in patients with underlying renal impairment like diabetic nephropathy.

Question 12

A patient with severe cirrhosis and ascites is treated with high-dose furosemide. Despite initial diuresis, their ascites reaccumulates, and they develop hypokalemia. Spironolactone is added to their regimen.

What is the primary rationale for adding spironolactone to furosemide in this patient?

  1. To directly block sodium reabsorption in the proximal tubule, which is unaffected by furosemide.
  2. To counteract the secondary hyperaldosteronism that drives diuretic resistance and potassium wasting. (correct answer)
  3. To increase the synthesis of natriuretic peptides, which are deficient in patients with cirrhosis.
  4. To inhibit the action of ADH at the collecting duct, promoting aquaresis and correcting hyponatremia.
Explanation: The correct answer is B. In cirrhosis, splanchnic vasodilation reduces effective circulating volume, leading to profound activation of the RAAS (secondary hyperaldosteronism). High levels of aldosterone drive intense sodium reabsorption in the distal nephron. While furosemide blocks sodium reabsorption in the loop of Henle, much of this sodium is reabsorbed downstream under the influence of aldosterone. This limits furosemide's efficacy (diuretic resistance) and exacerbates potassium secretion. Spironolactone, an aldosterone antagonist, directly blocks this downstream effect, enhancing natriuresis and conserving potassium.

Question 13

A patient switches from an ACE inhibitor (lisinopril) to an angiotensin II receptor blocker (ARB) (losartan) due to a persistent cough. How would this change in medication be expected to affect the circulating levels of renin, angiotensin I, and angiotensin II?

  1. Angiotensin II levels will increase, while renin and angiotensin I levels will decrease.
  2. Angiotensin II, angiotensin I, and renin levels will all increase. (correct answer)
  3. Angiotensin II levels will decrease, similar to the effect of an ACE inhibitor.
  4. Angiotensin II and angiotensin I will decrease, while renin levels will increase.
Explanation: The correct answer is B. ARBs block the AT1 receptor, preventing angiotensin II from exerting its effects, including negative feedback on renin release. The loss of this negative feedback loop leads to a compensatory increase in plasma renin activity. Increased renin leads to increased production of angiotensin I, and subsequently, increased conversion to angiotensin II (since ACE is not inhibited). Thus, levels of all three components (renin, Ang I, and Ang II) increase, although the effects of Ang II are blocked at the receptor level.

Question 14

A 40-year-old female is diagnosed with primary hyperaldosteronism (Conn's syndrome) due to an adrenal adenoma. She has hypertension and hypokalemia but lacks significant peripheral edema.

The absence of severe edema in this patient is best explained by which physiological phenomenon?

  1. Suppression of renin and angiotensin II, which counteracts the sodium-retaining effects of aldosterone.
  2. The "aldosterone escape" mechanism, involving increased pressure natriuresis and ANP release. (correct answer)
  3. Downregulation of mineralocorticoid receptors in the collecting duct after prolonged stimulation.
  4. A paradoxical decrease in ADH secretion despite the hypervolemic state.
Explanation: The correct answer is B. In primary hyperaldosteronism, the initial aldosterone-driven sodium and water retention causes volume expansion and hypertension. This expansion increases renal perfusion pressure and stretches the cardiac atria, leading to pressure natriuresis and the release of Atrial Natriuretic Peptide (ANP). ANP promotes sodium and water excretion by increasing GFR and directly inhibiting sodium reabsorption in the collecting duct. This counter-regulatory response allows the kidney to "escape" the full sodium-retaining effect of aldosterone, establishing a new steady state with mild hypervolemia and hypertension but without progressive edema formation.

Question 15

A patient with nephrotic syndrome presents with massive proteinuria, hypoalbuminemia, and generalized edema. Their blood pressure is 100/60 mmHg. Which statement most accurately describes the role of the RAAS in this patient's edema formation?

  1. RAAS is suppressed due to total body volume overload, which limits further edema.
  2. RAAS activity is normal, as edema is caused exclusively by low plasma oncotic pressure.
  3. RAAS is activated solely due to renal ischemia caused by glomerular damage.
  4. RAAS is activated due to decreased effective circulating volume, driving primary renal sodium retention. (correct answer)
Explanation: When you encounter nephrotic syndrome questions, focus on the concept of effective circulating volume versus total body fluid volume—these can move in opposite directions and drive different physiological responses. In nephrotic syndrome, massive protein loss creates hypoalbuminemia, which reduces plasma oncotic pressure. This allows fluid to shift from the intravascular space into the interstitium, causing edema. Critically, this fluid shift reduces the effective circulating volume (the portion of blood volume that effectively perfuses organs), even though total body fluid is increased. The low blood pressure (100/60 mmHg) confirms reduced effective circulation. The kidneys respond to this decreased effective circulating volume by activating RAAS, which promotes sodium and water retention to restore intravascular volume. However, because the underlying problem (low albumin) persists, this retained fluid also leaks into tissues, worsening edema while the kidneys continue sensing volume depletion. Answer D correctly identifies this mechanism—RAAS activation due to decreased effective circulating volume driving primary renal sodium retention. Answer A is wrong because RAAS responds to effective circulating volume, not total body volume overload. Answer B incorrectly suggests RAAS plays no role when it's actually a major contributor to the sodium retention that perpetuates edema. Answer C oversimplifies by attributing RAAS activation solely to renal ischemia, missing the primary mechanism of reduced effective circulation. Study tip: Remember that in edematous states, always distinguish between total body fluid (often increased) and effective circulating volume (often decreased)—the kidneys respond to the latter.

Question 16

A patient is given an experimental drug that selectively and potently blocks the AT2 receptor, leaving the AT1 receptor unaffected. What is the most likely physiological consequence of administering this drug?

  1. A significant decrease in blood pressure and natriuresis.
  2. Inhibition of aldosterone release with preservation of vasoconstrictor effects.
  3. A clinical picture identical to that of an ACE inhibitor, including cough.
  4. An unopposed, exaggerated effect of AT1 receptor stimulation, such as increased vasoconstriction. (correct answer)
Explanation: When you encounter questions about selective receptor blockade, think about the balance between opposing receptor subtypes and what happens when you tip that balance. The renin-angiotensin system has two main receptor types with opposing effects. AT1 receptors mediate the "bad" effects of angiotensin II: vasoconstriction, aldosterone release, and sodium retention. AT2 receptors generally oppose these actions, promoting vasodilation, natriuresis, and anti-proliferative effects. These receptors normally work in balance to modulate angiotensin II's overall impact. By selectively blocking AT2 receptors while leaving AT1 receptors intact, you remove the counterbalancing effects. Now angiotensin II can only bind to AT1 receptors, creating an unopposed, exaggerated response. This means enhanced vasoconstriction, increased aldosterone release, and greater sodium retention - essentially amplifying all the harmful cardiovascular effects. Answer D correctly identifies this unopposed AT1 stimulation. Answer A is backwards - blocking the protective AT2 receptors would increase blood pressure and reduce natriuresis. Answer B misunderstands the receptor roles; AT2 blockade wouldn't inhibit aldosterone (that's an AT1 effect) but would actually allow more aldosterone release. Answer C incorrectly assumes AT2 blockade mimics ACE inhibition, when it actually does the opposite - ACE inhibitors reduce angiotensin II formation, while AT2 blockade shifts existing angiotensin II toward harmful AT1 effects. Remember: when studying receptor systems, always consider whether receptors work synergistically or antagonistically. Blocking one member of an antagonistic pair amplifies the other's effects.

Question 17

A patient with primary adrenal insufficiency (Addison's disease) is admitted to the hospital in an adrenal crisis, characterized by severe hypotension and vomiting.

Which set of electrolyte and acid-base abnormalities is most consistent with the pathophysiology of this patient's condition?

  1. Hyponatremia, hyperkalemia, and a non-anion gap metabolic acidosis. (correct answer)
  2. Hypernatremia, hypokalemia, and a metabolic alkalosis.
  3. Hyponatremia, hypokalemia, and a respiratory acidosis.
  4. Hypernatremia, hyperkalemia, and a non-anion gap metabolic alkalosis.
Explanation: The correct answer is A. Primary adrenal insufficiency involves the destruction of the adrenal cortex, leading to a deficiency of both cortisol and aldosterone. The lack of aldosterone impairs the function of the distal nephron, resulting in: 1) inability to reabsorb sodium, leading to volume depletion and hyponatremia; 2) inability to secrete potassium, leading to hyperkalemia; and 3) inability to secrete hydrogen ions, leading to a non-anion gap metabolic acidosis. The hypotension is due to both volume depletion (aldosterone deficiency) and loss of cortisol's permissive effect on catecholamines.

Question 18

A patient is started on aliskiren, a direct renin inhibitor, for the management of hypertension.

What is the expected effect of this drug on the levels of plasma renin activity (PRA), angiotensin I, and angiotensin II?

  1. PRA decreased, Angiotensin I decreased, Angiotensin II decreased. (correct answer)
  2. PRA increased, Angiotensin I increased, Angiotensin II increased.
  3. PRA decreased, Angiotensin I increased, Angiotensin II increased.
  4. PRA increased, Angiotensin I decreased, Angiotensin II decreased.
Explanation: The correct answer is A. Aliskiren is a direct renin inhibitor. It binds to the active site of renin and prevents it from cleaving angiotensinogen to form angiotensin I. This blocks the very first and rate-limiting step of the RAAS cascade. Consequently, plasma renin activity (PRA), which measures the rate of angiotensin I generation, will decrease. Since less angiotensin I is formed, levels of angiotensin II will also decrease. Note: While plasma renin concentration might increase due to loss of negative feedback, the question asks for plasma renin activity, which is inhibited by the drug.

Question 19

A 62-year-old male with resistant hypertension undergoes an evaluation that reveals 90% stenosis of his left renal artery. The right kidney and its artery are anatomically normal. Renal vein catheterization is performed to measure renin levels from both kidneys.

Which of the following patterns of renin secretion is expected in this patient?

  1. Markedly elevated renin from the left renal vein and suppressed renin from the right renal vein. (correct answer)
  2. Markedly elevated renin from both the left and right renal veins.
  3. Suppressed renin from the left renal vein and markedly elevated renin from the right renal vein.
  4. Suppressed renin from both the left and right renal veins due to high systemic blood pressure.
Explanation: The correct answer is A. The stenosis in the left renal artery causes profound hypoperfusion of the left kidney. The juxtaglomerular apparatus of the left kidney interprets this as systemic hypotension and dramatically increases renin secretion. This high level of renin enters the systemic circulation, activating the RAAS and causing severe hypertension. The healthy right kidney is exposed to this high systemic blood pressure, which, along with high levels of angiotensin II, provides strong negative feedback to its juxtaglomerular cells, suppressing its renin release.

Question 20

The integration of the baroreceptor reflex and the RAAS is essential for blood pressure homeostasis. Following a sudden, severe hemorrhage, which of the following represents the most rapid compensatory vasoconstrictor response?

  1. Increased aldosterone release causing sodium and water retention.
  2. Increased angiotensin II formation leading to systemic vasoconstriction.
  3. Increased norepinephrine release from sympathetic nerve terminals. (correct answer)
  4. Increased ADH release from the posterior pituitary.
Explanation: The correct answer is C. The baroreceptor reflex is the body's fastest mechanism for responding to changes in blood pressure. A drop in pressure, as seen in hemorrhage, is sensed by baroreceptors in the carotid sinus and aortic arch. This leads to a near-instantaneous increase in sympathetic outflow from the brainstem. The release of norepinephrine at vascular smooth muscle nerve endings causes rapid, widespread vasoconstriction to increase total peripheral resistance and support blood pressure within seconds.